This inventor holds 11 USPTO granted patents and 7 published patent applications and 5 EPO patents. Top assignees: Hyundai Motor Company, Kia Corporation, Korea Institute of Science and Technology. Active years: 2012-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gyeonggi-do, KR (2012 - 2016)
- Seoul, KR (2024)
Company Filing History:
4 out of 20,313 
3 out of 5,796 
3 out of 2,248 
Years Active: 2012-2026
Title: The Innovative Journey of Hwan Kim in Pharmaceutical Science
Introduction
Hwan Kim, an accomplished inventor based in Seoul, South Korea, has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a total of three patents to his name, Kim's work focuses primarily on advanced therapeutic solutions for cancer and protein kinase-related diseases.
Latest Patents
One of Hwan Kim's most noteworthy patents is the development of an N-containing heteroaryl derivative that serves as an active ingredient in pharmaceutical compositions for the prevention or treatment of cancer. This invention is particularly notable for its high inhibitory activity against various protein kinases, specifically demonstrating excellent effectiveness against the RET proto-oncogene enzyme. The derivative shows promise in inhibiting the proliferation of medullary thyroid cancer and lung cancer cells expressing RET fusion genes.
Another significant patent by Kim involves a pyrrolopyridine derivative, which is also utilized in pharmaceutical formulations aimed at preventing or treating protein kinase-related diseases. This innovative compound exhibits superior inhibitory activity against multiple protein kinases, including LRRK2, DYRK1, and CLK1. Such a compound is particularly effective in treating triple-negative breast cancer, making it a crucial advancement in oncology.
Career Highlights
Hwan Kim's expertise has been shaped by his valuable experiences with several innovative firms. Notably, he has worked with Voronoi Inc. and Sqand Co. Ltd., where he contributed to cutting-edge research and development projects within the pharmaceutical industry. His role in these companies has allowed him to refine his skills and advance his research in drug development significantly.
Collaborations
Throughout his career, Hwan Kim has collaborated with distinguished colleagues, including Yang-Hann Kim and Jong-Hwa Lee. These partnerships not only enriched his research experiences but also fostered a collaborative environment that emphasizes innovation and creative solutions in tackling complex medical challenges.
Conclusion
Hwan Kim stands out as a pioneering inventor in the pharmaceutical field, with notable advancements in cancer treatment and protein kinase-related diseases. His work exemplifies the importance of innovation in medicine, aiming to improve therapeutic outcomes for patients facing dire health challenges. As he continues to explore new avenues for research and development, Kim's future contributions to science and medicine are anticipated with great interest.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile